Related Experiment Video

Updated: Aug 16, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

APAF-1 signaling in human melanoma

Andrea Anichini1, Roberta Mortarini, Marialuisa Sensi

  • 1Unit of Human Tumor Immunobiology, Dept. of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133, Milan, Italy. andrea.anichini@istitutotumori.mi.it

Cancer Letters
|August 13, 2005
PubMed

Insights

Cancer cells, like melanoma, can evade programmed cell death by inactivating Apoptotic Protease Activating Factor-1 (APAF-1). However, APAF-1-independent pathways allow apoptosis, suggesting context-dependent roles in cancer drug resistance.

Area of Science:

  • Cellular biology
  • Cancer research
  • Molecular mechanisms of cell death

Background:

  • Acquired resistance to programmed cell death is a hallmark of advanced human melanoma, hindering curability.
  • Strategies to evade apoptosis include impairing death receptor and mitochondrial pathways, often involving inactivation of key factors like Apoptotic Protease Activating Factor-1 (APAF-1).
  • APAF-1 is crucial for the intrinsic apoptosis pathway, linking mitochondrial cytochrome c release to caspase-9 activation.

Purpose of the Study:

  • To investigate the role of Apoptotic Protease Activating Factor-1 (APAF-1) in chemoresistance and tumor progression in human melanoma.
  • To explore the significance of APAF-1 in mediating apoptosis induced by chemotherapeutic drugs.
  • To understand the context-dependent relevance of the APAF-1 pathway in programmed cell death in cancer.

Main Methods:

  • Analysis of APAF-1 expression in human melanoma.
  • In vivo studies correlating APAF-1 loss with tumor progression.
  • Investigation of melanoma cell apoptosis in response to pro-apoptotic drugs, assessing APAF-1 dependency.

Main Results:

  • Inactivation of APAF-1 in human melanoma may contribute to chemoresistance by impairing the mitochondrial apoptosis pathway, particularly for p53-activating drugs.
  • Loss of APAF-1 expression in vivo is associated with tumor progression, suggesting a survival advantage for neoplastic cells.
  • Melanoma cells can undergo apoptosis via APAF-1-independent pathways, indicating that APAF-1 expression is not always essential for drug-induced cell death.

Conclusions:

  • The relevance of the APAF-1 pathway in programmed cell death is context-dependent, varying with cell type and the specific pro-apoptotic stimulus.
  • APAF-1 inactivation is a potential mechanism of chemoresistance in melanoma, but alternative apoptotic pathways exist.
  • Understanding APAF-1-independent apoptosis is crucial for developing effective cancer therapies against resistant tumors.

More Related Videos

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...